Evaluation of immuno-1 toxoplasma IgG assay in the prenatal screening of toxoplasmosis.
We evaluated the Immuno-1 (Bayer Diagnostics, Tarrytown, New York, USA) and IMx (Abbott Laboratories, Chicago, Illinois, USA) toxoplasma IgG assays in 298 (223 fresh in-house prenatal + 75 supplied by Bayer) specimens over 15 days. Discordant results were resolved by indirect fluorescence assay (Gull Laboratories, Salt Lake City, Utah, USA). The performance of Immuno-1 assay was found to be comparable to the IMx assay. Immuno-1, being a random access analyzer with minimum hands-on time requirements may have an advantage in the overall laboratory efficiency.
Rao
L V
LV
Division of Clinical Chemistry, University of Texas Medical Branch, Galveston 77555, USA.
James
O A
OA
Mann
L M
LM
Mohammad
A A
AA
Okorodudu
A O
AO
Bissell
M G
MG
Petersen
J R
JR
D000818:Animals; D000913:Antibodies, Protozoan / Q000032:analysis* / Q000276:immunology*; D005260:Female; D019084:Fluorescent Antibody Technique, Indirect; D006801:Humans; D007118:Immunoassay / Q000379:methods*; D007074:Immunoglobulin G / Q000032:analysis* / Q000276:immunology*; D011247:Pregnancy; D015597:Pregnancy Complications, Parasitic / Q000175:diagnosis / Q000276:immunology; D012680:Sensitivity and Specificity; D014122:Toxoplasma / Q000276:immunology*; D014123:Toxoplasmosis / Q000175:diagnosis* / Q000276:immunology*
D000913:Antibodies, Protozoan; D007074:Immunoglobulin G